Claim/exemption information - Registry number 11884

Correct the disclosure of misleading cross-referencing between SDS sections.

Correct the precautionary statements to select the appropriate phrase(s) when a slash is present.

Disclose a clear link between all of the applicable confidential business information and the HMIRA registry number.

Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

Disclose an adequate concentration unit.

Disclose an adequate emergency telephone number.

Disclose an adequate product odour.

Disclose incompatibilities of the hazardous product.

Disclose the additional hazard classification of “Eye Irritation — Category 2”.

Disclose the additional information elements in section 7, “Handling and storage”, and section 4, “First-aid measures”.

Disclose the additional ingredient “alcohols, C11-15-secondary, ethoxylated”.

Disclose the applicable common names and synonyms for the ingredients “diethylene glycol monobutyl ether” and “alcohols, C11-15-secondary, ethoxylated”.

Disclose the information elements concerning the additional hazard and precautionary statements.

Disclose the likely routes of exposure in section 11, “Toxicological information”.

Disclose the percent of unknown toxicity of “2%” for the calculated product oral ATE value.

Disclose the product’s relative density.

Disclose the symptoms related to the physical, chemical and toxicological characteristics.